Instadose Pharma Corp.
INSD
$0.00
$0.000.00%
OTC PK
| 02/28/2022 | |||||
|---|---|---|---|---|---|
| Net Income | 91.31% | ||||
| Total Depreciation and Amortization | 0.32% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -- | ||||
| Change in Net Operating Assets | 1,084.94% | ||||
| Cash from Operations | 130.03% | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | 102.04% | ||||
| Cash from Investing | 102.04% | ||||
| Total Debt Issued | -96.39% | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -122.31% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -151.35% | ||||